VUNO Inc.

VUNO Med®-DeepCARS™

VUNO Med-DeepCARS

Provides risk of cardiac arrest of patients in the general wards within 24 hours through vital sign data.

Request a Demo
  • AI-based cardiac arrest risk management system
  • The breakthrough medical device by the Korea Ministry of Food and Drug Safety
  • MFDS(K-FDA) approved

Opening A New Era in Managing In-Hospital Cardiac Arrest

VUNO Med®- DeepCARS™ is Korea’s first AI medical device that provides a 1-100 risk score of inpatient cardiac arrest in the general wards within 24 hours through vital signs, which helps effective patient monitoring and risk management.

Simple

Simple

Uses only 4 vital signs to provide cardiac arrest risk score.

Effective

Effective

From a multicenter study (173,368 patients), DeepCARS™ proved its performance accuracy (AUROC) to predict cardiac arrest within 24 hours in various environment, Internal validation cohort 0.860 and external validation cohort 0.905.

References. A multicenter validation study of the deep learning-based early warning score for predicting in-hospital cardiac arrest in patients admitted to general wards. Resuscitation. 2021 Apr.

Efficient

Efficient

The average time from the first prediction of cardiac arrest to the actual occurrence is 15.8 hours, which could enable more rapid and efficient responses to in-hospital cardiac arrest by predicting a cardiac event in advance.

MFDS clinical trial results (VN-M-05) in Asan Hospital, *Retrospective case-control study

Related News

Request a Demo for VUNO Med®-DeepCARS™

Apply for a VUNO Med® solution demo!
Check to see how VUNO Inc. can help you technologically.

Request a Demo